Evans syndrome occurring in a young patient with autoimmune lymphoproliferative syndrome (ALPS) is a clinically distinct scenario. The underlying immune dysregulation of ALPS substantially influences which treatments are appropriate and which must be avoided.
Clinical context: This protocol is for Evans syndrome in the setting of autoimmune lymphoproliferative syndrome (ALPS) in young patients. The coexistence of ALPS defines the boundaries of safe and effective management in this population.
Management involves a specific targeted medical agent. Critically, a surgical intervention that is sometimes considered in Evans syndrome is contraindicated in this ALPS context due to serious infection risk.
Full regimen details, including sequencing and clinical parameters, are available in the complete protocol.
For young patients with ALPS, sirolimus may be a good option, whereas splenectomy must be avoided as the risk of overwhelming postsplenectomy infections is very high in this patient population.
View source ↗